A Study of Genetic Profiling of Peyronie's Disease Patients


About this study

The purpose of this study is to provide comprehensive genetic profiling of Peyronie's Disease (PD) patients, discover candidate genes associated with the disease, and to compare the identified candidate genetic mutations/variations with familial and non-familial cases.




Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Men aged 45-70 years old (for initial screening); 
  • Diagnosis of Peyronie's Disease (PD); OR 
  • Male family members of men with PD (>18 years old).

Exclusion Criteria: 

  • None.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Ziegelmann, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer